These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20652713)

  • 101. Retrospective analysis of the diagnostic yield of newborn drug testing.
    Wood KE; Sinclair LL; Rysgaard CD; Strathmann FG; McMillin GA; Krasowski MD
    BMC Pregnancy Childbirth; 2014 Jul; 14():250. PubMed ID: 25073780
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Measuring substance use in the club setting: a feasibility study using biochemical markers.
    Gripenberg-Abdon J; Elgán TH; Wallin E; Shaafati M; Beck O; Andréasson S
    Subst Abuse Treat Prev Policy; 2012 Feb; 7():7. PubMed ID: 22321198
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Portable fully automated oral fluid extraction device for illegal drugs.
    Růžička M; Kaljurand M; Gorbatšova J; Vaher M; Mazina-Šinkar J
    Talanta; 2022 Jun; 243():123389. PubMed ID: 35298928
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Illicit substances identified in the urine of 11.170 suspected drug users in North Tunisia.
    Chaouali N; Moslah B; Salem KB; Amira D; Hedhili A; Salah NB
    Pan Afr Med J; 2021; 38():20. PubMed ID: 34567345
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Early Warning System for Illicit Drug Use at Large Public Events: Trace Residue Analysis of Discarded Drug Packaging Samples.
    West H; Fitzgerald J; Hopkins K; Li E; Clark N; Tzanetis S; Greene SL; Reid GE
    J Am Soc Mass Spectrom; 2021 Oct; 32(10):2604-2614. PubMed ID: 34460248
    [TBL] [Abstract][Full Text] [Related]  

  • 106. [Estimation of the usage of psychoactive substances in academic campus based on analysis of municipal waste water].
    Wiergowski M; Sołtyszewski I; Szymańska U; Zebek E; Jankowski Z; Sein Anand J
    Przegl Lek; 2012; 69(8):439-43. PubMed ID: 23243903
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Emerging trends in point-of-care sensors for illicit drugs analysis.
    Dagar M; Yadav S; Sai VVR; Satija J; Bhatia H
    Talanta; 2022 Feb; 238(Pt 2):123048. PubMed ID: 34801905
    [TBL] [Abstract][Full Text] [Related]  

  • 108. On-site illicit-drug detection with an integrated near-infrared spectral sensor: A proof of concept.
    Kranenburg RF; Ou F; Sevo P; Petruzzella M; de Ridder R; van Klinken A; Hakkel KD; van Elst DMJ; van Veldhoven R; Pagliano F; van Asten AC; Fiore A
    Talanta; 2022 Aug; 245():123441. PubMed ID: 35405444
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Novel technologies in detection, treatment and prevention of substance use disorders.
    Moulahoum H; Zihnioglu F; Timur S; Coskunol H
    J Food Drug Anal; 2019 Jan; 27(1):22-31. PubMed ID: 30648574
    [TBL] [Abstract][Full Text] [Related]  

  • 110. 21-year-old woman with palpitations and vomiting.
    Stanich PP; Mueller PS
    Mayo Clin Proc; 2010 Sep; 85(9):e61-4. PubMed ID: 20810789
    [No Abstract]   [Full Text] [Related]  

  • 111. Roadside screening tests for cannabis use: A systematic review.
    Wennberg E; Windle SB; Filion KB; Thombs BD; Gore G; Benedetti A; Grad R; Ells C; Eisenberg MJ
    Heliyon; 2023 Apr; 9(4):e14630. PubMed ID: 37064483
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Concordance of self-reported drug use and saliva drug tests in a sample of emergency department patients.
    Macdonald S; Cherpitel CJ; Stockwell T; Martin G; Ishiguro S; Vallance K; Brubacher J
    J Subst Use; 2014 Mar; 19(1-2):147-151. PubMed ID: 25104914
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls.
    Avcioglu G; Yilmaz G; Yalcin Sahiner S; Kozaci LD; Bal C; Yilmaz FM
    Clin Biochem; 2021 Jul; 93():112-118. PubMed ID: 33882283
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.
    Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F
    Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427
    [TBL] [Abstract][Full Text] [Related]  

  • 115. [Clinical and analytical toxicology of opiate, cocaine and amphetamine].
    Feliu C; Fouley A; Millart H; Gozalo C; Marty H; Djerada Z
    Ann Biol Clin (Paris); 2015; 73(1):54-69. PubMed ID: 25582723
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Performance evaluation of the DrugWipe® 5/5+ on-site oral fluid screening device.
    Pehrsson A; Blencowe T; Vimpari K; Impinen A; Gunnar T; Lillsunde P
    Int J Legal Med; 2011 Sep; 125(5):675-83. PubMed ID: 20652713
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
    Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
    Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
    [TBL] [Abstract][Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.